Completed Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists NCT06003985 Conditions Gastric Ultrasound, Glucagon-like Peptide 1, Point of Care Ultrasound Locations George Washington University Hospital — Washington D.C., District of Columbia, United States Mayo Clinic — Jacksonville, Florida, United States Albany Medical Center — Albany, New York, United States Hospital for Special Surgery — New York, United States View more locations Show fewer locations Loading locations... View Trial Details
Completed Effects of GLP-1 Agonists on Gastric Volume NCT05854979 Conditions Deglutition Disorders, Diabetes, Diabetes Mellitus, +19 more Locations Medical University of South Carolina — Charleston, South Carolina, United States View Trial Details
Completed Effect of LIXIsenatide on the Renal System NCT02276196 Conditions Diabetes Complications, Diabetes Mellitus, Diabetic Kidney Disease, +13 more Locations VU Universtiy Medical Center — Amsterdam, Netherlands View Trial Details
Completed Effects of Exendin(9-39) on Gastroduodenal Motility NCT00468091 Conditions Digestive Physiology, Exendin (9-39), Gastrointestinal Hormones, +2 more Locations Clinical Research unit, Dept. of Internal Medicine II - Großhadern, University of Munich — Munich, Germany View Trial Details
